Filtered By:
Cancer: Adenocarcinoma
Therapy: External Beam Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 50 results found since Jan 2013.
Metastatic Lung Adenocarcinoma: A Case of Unusual Presentation With a Skull Mass
This report focuses on the clinical presentation and treatment of an elderly male patient who had a progressively enlarging and painful skull mass. The initial imaging revealed an about 5 cm soft tissue mass at the dorsal midline of the parietal-occipital bone. Subsequent imaging identified a lung mass, and a biopsy of the skull bone confirmed that the mass was metastatic adenocarcinoma originating from the lung. For treatment, the patient underwent occipital partial resection of the mass, followed by wire mesh cranioplasty. Chemotherapy and external beam radiotherapy were administered to alleviate symptoms and control the...
Source: Cancer Control - August 25, 2023 Category: Cancer & Oncology Authors: Jaha Oh Eunhee Choi Richa Aggarwal Source Type: research
Acute angle-closure related with choroidal metastasis from lung adenocarcinoma: A case report and literature review
CONCLUSION: This case demonstrated that patient with secondary acute angle-closure attacks from large bullous choroidal detachment related to choroidal metastasis could only be successfully treated with radiotherapy as both medical and laser therapy might not be capable of breaking angle-closure attacks.PMID:37424265 | DOI:10.1177/11206721231187425
Source: European Journal of Ophthalmology - July 10, 2023 Category: Opthalmology Authors: Chen-Jung Kuo Chih-Heng Hung Pei-Ning Tu Yi-Chun Chen Source Type: research
Rapid vision improvement by using icotinib in a patient with bilateral choroidal metastases symmetrically from lung cancer
CONCLUSION: Bilateral choroidal metastases from lung cancer symmetrically are very rare. Icotinib following by almonertinib was an alternative therapy for choroidal metastasis from non-small cell lung cancer with epithelial growth factor receptor mutation.PMID:37315930 | DOI:10.1111/crj.13649
Source: Clinical Lung Cancer - June 14, 2023 Category: Cancer & Oncology Authors: Chaoran Li Xue E Wang Lei Yan Yani Zhao Yun Kui Zhu Source Type: research
Outcomes following external beam radiotherapy to the prostate and pelvic lymph nodes in addition to androgen deprivation therapy in non-metastatic prostate adenocarcinoma with regional lymph node involvement: a retrospective cohort study
CONCLUSION: Patients with cN1 disease should be considered for PPLN EBRT, in addition to ADT. Treatment is well tolerated with low toxicity, good locoregional control, and prolonged time to disease progression.ADVANCES IN KNOWLEDGE: We report real-world experience of cN1 patients treated with PPLN EBRT in addition to ADT, with good outcomes following treatment and low toxicity.PMID:37035766 | PMC:PMC10077404 | DOI:10.1259/bjro.20220030
Source: Cancer Control - April 10, 2023 Category: Cancer & Oncology Authors: Akmal Mohamad Roji Rahul Sandhu Anjali Zarkar Source Type: research
Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer
CONCLUSIONS: Compared to conventional dose RT, dose-escalated RT probably results in little to no difference in time to death from prostate cancer, time to death from any cause, time to distant metastasis, and RT toxicities (except overall late GI toxicity). While dose-escalated RT may increase overall late GI toxicity, it may result, or probably results, in little to no difference in physical and mental quality of life, respectively.PMID:36884035 | DOI:10.1002/14651858.CD012817.pub2
Source: Cochrane Database of Systematic Reviews - March 8, 2023 Category: General Medicine Authors: Sunghyun Kim Jee Hyun Kong YoHan Lee Jun Young Lee Tae Wook Kang Tae Hoon Kong Myung Ha Kim Sei Hwan You Source Type: research
The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer
CONCLUSIONS: Our study provided a comprehensive view of the treatment effect of RP and EBRT in non-adenocarcinoma PCa patients. These findings could facilitate clinicians in making therapeutic decision-making for non-adenocarcinoma patients.PMID:36376185 | DOI:10.1016/j.asjsur.2022.11.004
Source: Asian Journal of Surgery - November 14, 2022 Category: Surgery Authors: Jinge Zhao Guangxi Sun Fengnian Zhao Junru Chen Sha Zhu Nanwei Xu Haoyang Liu Jiayu Liang Xu Hu Xingming Zhang Yuchao Ni Jindong Dai Zhipeng Wang Pengfei Shen Zhenhua Liu Ni Chen Jiyan Liu Hao Zeng Source Type: research
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
We report 2-year toxicity findings from PACE-B, a randomised trial of conventionally fractionated or moderately hypofractionated radiotherapy versus SBRT.METHODS: PACE is an open-label, multicohort, randomised, controlled, phase 3 trial conducted at 35 hospitals in the UK, Ireland, and Canada. In PACE-B, men aged 18 years and older with a WHO performance status 0-2 and low-risk or intermediate-risk histologically-confirmed prostate adenocarcinoma (Gleason 4 + 3 excluded) were randomly allocated (1:1) by computerised central randomisation with permuted blocks (size four and six), stratified by centre and risk group to contr...
Source: Cancer Control - September 16, 2022 Category: Cancer & Oncology Authors: Alison C Tree Peter Ostler Hans van der Voet William Chu Andrew Loblaw Daniel Ford Shaun Tolan Suneil Jain Alexander Martin John Staffurth John Armstrong Philip Camilleri Kiran Kancherla John Frew Andrew Chan Ian S Dayes Aileen Duffton Douglas H Brand Dan Source Type: research
CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)
Int J Gynecol Cancer. 2022 Sep 13:ijgc-2022-003918. doi: 10.1136/ijgc-2022-003918. Online ahead of print.ABSTRACTBACKGROUND: The role of adjuvant treatment in the intermediate-risk group of patients with early-stage cervical cancer is controversial and is supported by a single randomized Gynecologic Oncology Group (GOG) 92 study performed more than 20 years ago. Recent retrospective studies have shown excellent local control in this group of patients after radical surgery with no additional adjuvant treatment.PRIMARY OBJECTIVE: To evaluate if adjuvant (chemo)radiation is associated with a survival benefit after radical sur...
Source: Cancer Control - September 13, 2022 Category: Cancer & Oncology Authors: David Cibula Martina Bor činová Roman Kocian David Feltl Sona Argalacsova Pavel Dvorak Daniela Fischerov á Pavel Dundr Jiri Jarkovsky Eva H öschlová Jiri Slama Giovanni Scambia Source Type: research
External beam radiation therapy treatment factors prognostic of biochemical failure free survival: a multi-institutional retrospective study for prostate cancer
CONCLUSION: EBRT features prognostic of BFFS were identified and a random survival forest was developed for predicting prostate cancer patients' BFFS after EBRT.PMID:35662659 | DOI:10.1016/j.radonc.2022.05.030
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - June 6, 2022 Category: Radiology Authors: Lingyue Sun Harvey Quon Vicki Tran Charles Kirkby Wendy Smith Source Type: research
